Optimizing Treatment for Cutaneous Leishmaniasis with WR279396
Author Information
Author(s): Lecoeur Hervé, Buffet Pierre, Morizot Gloria, Goyard Sophie, Guigon Ghislaine, Milon Geneviève, Lang Thierry
Primary Institution: Institut Pasteur, Paris, France
Hypothesis
Can the efficacy of topical therapy for localized cutaneous leishmaniasis be improved using an occlusive dressing?
Conclusion
Using an occlusive dressing significantly enhances the efficacy of WR279396 in treating localized cutaneous leishmaniasis in mice.
Supporting Evidence
- 94% efficacy of WR279396 was observed with 10 daily applications in mice.
- Occlusive dressing significantly increased treatment efficacy compared to no dressing.
- Length of therapy was found to be more important than total dose applied.
Takeaway
This study found that a special ointment works better for treating skin infections when covered with a bandage, helping the medicine work faster and better.
Methodology
C57BL/6 mice were inoculated with L. major and treated with WR279396, with efficacy assessed through bioluminescence imaging and lesion size measurements.
Potential Biases
Potential bias in treatment allocation and assessment due to the lack of blinding.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
C57BL/6 mice, female, 5 weeks old.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website